Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

✍ Scribed by Kuemmerle-Deschner, Jasmin B; Ramos, Eduardo; Blank, Norbert; Roesler, Joachim; Felix, Sandra D; Jung, Thomas; Stricker, Kirstin; Chakraborty, Abhijit; Tannenbaum, Stacey; Wright, Andrew M; Rordorf, Christiane

• Book ID: 120508421
• Publisher: BioMed Central
• Year: 2011
• Tongue: English
• Weight: 412 KB
• Volume: 13
• Category: Article
• ISSN: 1478-6354
• DOI: 10.1186/ar3266